Brandywine Pharmaceuticals

Brandywine Pharmaceuticals was a specialty pharmaceutical company focused on the acquisition, development, and commercialization of products for the treatment of central nervous system (CNS) disorders and pain management. Founded by former executives of Endo Pharmaceuticals, the company utilized a business model centered on acquiring late-stage or approved products to optimize their commercial value. The company was notably acquired by Endo Pharmaceuticals in 2002, which integrated Brandywine's assets into its growing pain management portfolio. This acquisition allowed Endo to expand its market presence and leverage the expertise of the Brandywine leadership team.